Plasminogen activator as a prognostic factor in hematological malignancies.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002478:Cells, Cultured; D019411:Clinical Laboratory Techniques; D006801:Humans; D007951:Leukemia, Myeloid / Q000378:metabolism / Q000473:pathology*; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology*; D010960:Plasminogen Activators / Q000378:metabolism*; D011379:Prognosis; D014568:Urokinase-Type Plasminogen Activator / Q000378:metabolism
D010960:Plasminogen Activators; D014568:Urokinase-Type Plasminogen Activator